Larimar Therapeutics, Inc. LRMR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-06-19
Larimar Therapeutics, Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| BlackRock Finance, Inc. | 3,134,050 | $22.7M |
| MILLENNIUM MANAGEMENT LLC | 3,625,278 | $16.3M |
| Point72 Asset Management, L.P. | 1,047,385 | $4.7M |
| AQR CAPITAL MANAGEMENT LLC | 817,517 | $3.7M |
| RENAISSANCE TECHNOLOGIES LLC | 739,942 | $3.3M |
| CITADEL ADVISORS LLC | 600,132 | $2.7M |
| D. E. Shaw & Co., Inc. | 575,624 | $2.6M |
| TWO SIGMA INVESTMENTS, LP | 475,612 | $2.1M |
Source: SEC EDGAR filings · CIK 0001374690 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.